Preclinical Research Outsourcing Services: Global Markets
Report Scope:
This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies. The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively covered as well. The report offers a detailed examination of preclinical services, analyzes market trends for preclinical research outsourcing services with data from 2020, estimates from 2021, and projections of CAGR through 2026 (forecast period 2021–2026).
This report provides a comprehensive analysis of the top preclinical CROs and evolving roles in the preclinical outsourcing services. CRO expertise within certain therapeutic areas and experience with new and adaptive study design protocols can reduce costs and study duration. CROs are expected to continue to play an increasing role in many aspects of the preclinical and clinical trial process.
Strong demand for CROs leads to heightened market assessments and many blockbuster mergers and acquisitions (M&As). M&A activity has led to a few companies to develop proficiency across many areas of the clinical trial process. However, niche players still play crucial roles. This report analyzes emerging trends and changing dynamics within the preclinical research outsourcing services industry.
Report Includes:
This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies. The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively covered as well. The report offers a detailed examination of preclinical services, analyzes market trends for preclinical research outsourcing services with data from 2020, estimates from 2021, and projections of CAGR through 2026 (forecast period 2021–2026).
This report provides a comprehensive analysis of the top preclinical CROs and evolving roles in the preclinical outsourcing services. CRO expertise within certain therapeutic areas and experience with new and adaptive study design protocols can reduce costs and study duration. CROs are expected to continue to play an increasing role in many aspects of the preclinical and clinical trial process.
Strong demand for CROs leads to heightened market assessments and many blockbuster mergers and acquisitions (M&As). M&A activity has led to a few companies to develop proficiency across many areas of the clinical trial process. However, niche players still play crucial roles. This report analyzes emerging trends and changing dynamics within the preclinical research outsourcing services industry.
Report Includes:
- 24 data tables and 12 additional tables
- An up-to-date review and analysis of the global markets for preclinical research outsourcing services
- Analyses of the global market trends, with historic revenue (sales) data from 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for preclinical research outsourcing services, projected growth trends, and corresponding market share analysis by functional services and geographic region
- In-depth information (facts and figures) concerning market drivers, market deterrents and other macroeconomic forces affecting the current and future market demand
- Identification of companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Regulatory structure for preclinical research studies in the pharmaceuticals industry, marketed and pipeline products, pricing and reimbursement structure, and major developments influencing the progress of this market
- Detailed analysis on the strength, weakness, and opportunities of the prominent players operating in the global preclinical research outsourcing services market
- Insight into recent industry structure, current competitive scenario, increasing investments on R&D activities, current pharma/CRO contracts and company value share analysis based on their segmental revenues
- Company profiles of major players, including Eurofins Scientific, IQVIA, Labcorp, SGS SA, and Thermo Fisher
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET DYNAMICS
Market Drivers
Rising R&D Investment
Growth in Outsourcing of Non-Core Function
CROs Add Efficiency
Market Restraints
Challenges in Preclinical Research Outsourcing
Lack of Skilled Professionals
Market Opportunities
Growing Opportunities in Asia-Pacific
Inorganic Strategies
Emerging Markets
CHAPTER 4 IMPACT OF COVID-19
Overview of COVID-19 Crisis
Impact of COVID-19 on the CRO Market
Current Outlook
CHAPTER 5 GLOBAL MARKET OVERVIEW
Preclinical Process Overview
Market for Drug Substance/Active Pharmaceutical Ingredient Manufacturing for Drug Development
Manufacturers
Market Estimate for Outsourcing API Manufacturing for Drug Development
Formulation and Dosage Design Outsourcing Services
Companies
Market Overview and Estimates for Outsourcing of Formulation Development
Analytical/Bioanalytical Methods Development, Validation and Testing
Analytical Methods Development
Analytical Methods Validation, Verification and Qualification
Analytical Testing Method Development and Validation Market Landscape and Estimates
Companies/Providers
Metabolism, Pharmacokinetics and Toxicology Outsourcing
Companies/Providers
Market Estimates: Metabolism, Pharmacokinetics and Toxicology Outsourcing Services
Preclinical Stage Outsourcing Services
CROs and Preclinical Research Outsourcing
Contract Manufacturing
Contract Research
CHAPTER 6 REGULATORY LANDSCAPE
FDA Regulation and Impact
Regulations on Sponsor Activities
The Declaration of Helsinki
CDISC Standards
Regulations for Contract Manufacturing Services
Regulations for Contract Pharmaceutical Clinical Research in Each Stage of Drug Discovery and Development Process
Current Market Trends
Existing Drugs for New Indications
Increased Competition
CHAPTER 7 MARKET ANALYSIS BY FUNCTIONAL SERVICE
Discovery Services
Chemistry
Bioanalysis
Toxicology
CHAPTER 8 MARKET ANALYSIS BY REGION
Overview
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Rest of Asia-Pacific
Rest of the World
South America
Middle East & Africa
CHAPTER 9 COMPETITIVE LANDSCAPE
Market Share Analysis
Current Pharma/CRO Contracts
Mergers and Acquisitions
CHAPTER 10 ANALYSIS OF MARKET OPPORTUNITIES
Porter's Five Forces Analysis
Threat of New Entrants
Threat of Substitutes
Bargaining Power of Suppliers
Bargaining Power of Buyers
Competitive Rivalry/Degree of Competition
SWOT Analysis
Strengths of the Global Market for Preclinical Research Outsourcing Services
Challenges within the Global Market for Preclinical Research Outsourcing Services
Opportunities in the Global Market for Preclinical Research Outsourcing Services
Threats to the Global Market for Preclinical Research Outsourcing Services
CHAPTER 11 COMPANY PROFILES
Top 11 CROs
CHARLES RIVER LABORATORIES
EUROFINS SCIENTIFIC
EVOTEC
FRONTAGE LABS
ICON PLC
IQVIA
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDPACE
SGS SA
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC
CHAPTER 12 APPENDIX: ABBREVIATIONS AND ACRONYMS
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET DYNAMICS
Market Drivers
Rising R&D Investment
Growth in Outsourcing of Non-Core Function
CROs Add Efficiency
Market Restraints
Challenges in Preclinical Research Outsourcing
Lack of Skilled Professionals
Market Opportunities
Growing Opportunities in Asia-Pacific
Inorganic Strategies
Emerging Markets
CHAPTER 4 IMPACT OF COVID-19
Overview of COVID-19 Crisis
Impact of COVID-19 on the CRO Market
Current Outlook
CHAPTER 5 GLOBAL MARKET OVERVIEW
Preclinical Process Overview
Market for Drug Substance/Active Pharmaceutical Ingredient Manufacturing for Drug Development
Manufacturers
Market Estimate for Outsourcing API Manufacturing for Drug Development
Formulation and Dosage Design Outsourcing Services
Companies
Market Overview and Estimates for Outsourcing of Formulation Development
Analytical/Bioanalytical Methods Development, Validation and Testing
Analytical Methods Development
Analytical Methods Validation, Verification and Qualification
Analytical Testing Method Development and Validation Market Landscape and Estimates
Companies/Providers
Metabolism, Pharmacokinetics and Toxicology Outsourcing
Companies/Providers
Market Estimates: Metabolism, Pharmacokinetics and Toxicology Outsourcing Services
Preclinical Stage Outsourcing Services
CROs and Preclinical Research Outsourcing
Contract Manufacturing
Contract Research
CHAPTER 6 REGULATORY LANDSCAPE
FDA Regulation and Impact
Regulations on Sponsor Activities
The Declaration of Helsinki
CDISC Standards
Regulations for Contract Manufacturing Services
Regulations for Contract Pharmaceutical Clinical Research in Each Stage of Drug Discovery and Development Process
Current Market Trends
Existing Drugs for New Indications
Increased Competition
CHAPTER 7 MARKET ANALYSIS BY FUNCTIONAL SERVICE
Discovery Services
Chemistry
Bioanalysis
Toxicology
CHAPTER 8 MARKET ANALYSIS BY REGION
Overview
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Rest of Asia-Pacific
Rest of the World
South America
Middle East & Africa
CHAPTER 9 COMPETITIVE LANDSCAPE
Market Share Analysis
Current Pharma/CRO Contracts
Mergers and Acquisitions
CHAPTER 10 ANALYSIS OF MARKET OPPORTUNITIES
Porter's Five Forces Analysis
Threat of New Entrants
Threat of Substitutes
Bargaining Power of Suppliers
Bargaining Power of Buyers
Competitive Rivalry/Degree of Competition
SWOT Analysis
Strengths of the Global Market for Preclinical Research Outsourcing Services
Challenges within the Global Market for Preclinical Research Outsourcing Services
Opportunities in the Global Market for Preclinical Research Outsourcing Services
Threats to the Global Market for Preclinical Research Outsourcing Services
CHAPTER 11 COMPANY PROFILES
Top 11 CROs
CHARLES RIVER LABORATORIES
EUROFINS SCIENTIFIC
EVOTEC
FRONTAGE LABS
ICON PLC
IQVIA
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDPACE
SGS SA
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC
CHAPTER 12 APPENDIX: ABBREVIATIONS AND ACRONYMS
LIST OF TABLES
Summary Table: Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, Through 2026
Table 1: R&D Investment, by Major Companies, 2019-2020
Table 2: Leading CROs in India
Table 3: Companies in the API Manufacturing Sector/Average Annual Revenues
Table 4: Companies Providing Formulation and Dosage Design Services for Drug Development (Examples)
Table 5: Distribution of Company Shares of the CDMO Sector by Revenue Range
Table 6: Companies Providing Analytical Testing Method Development and Validation Services for Drug Development (Examples)
Table 7: Companies Providing Drug Metabolism and Toxicology Services for Preclinical Drug Development (Examples)
Table 8: New Drug Approvals in the Global Biopharmaceuticals Market, 2006-2021
Table 9: Approved Drugs Repurposed for Infectious Diseases
Table 10: Global Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 11: Global Market for Discovery Services, by Region, Through 2026
Table 12: Global Market for Chemistry Services, by Region, Through 2026
Table 13: Global Market for Bioanalysis Services, by Region, Through 2026
Table 14: Global Market for Toxicology Services, by Region, Through 2026
Table 15: Global Market for Preclinical Research Outsourcing Services, by Region, Through 2026
Table 16: North American Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 17: European Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 18: Asia-Pacific Clinical Trial Regulatory Bodies
Table 19: Asia-Pacific Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 20: RoW Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 21: Pharma and CRO Partnership Alliances for Preclinical Research Services
Table 22: Recent M&As in CROs and Pharma Outsourcing Sector, 2016-2021
Table 23: Porter’s Five Forces Analysis
Table 24: Service Offerings, Major CROs
Table 25: Charles River Laboratories: Revenues, 2018-2020
Table 26: Eurofins Scientific: Revenue, 2018-2020
Table 27: Evotec: Revenues, 2018-2020
Table 28: Frontage Labs: Revenue, 2018-2020
Table 29: ICON plc: Revenue, 2018-2020
Table 30: IQVIA: Revenues, 2018-2020
Table 31: LabCorp: Revenue, 2018-2020
Table 32: Medpace: Revenues, 2018-2020
Table 33: SGS SA: Revenue, 2018-2020
Table 34: Thermo Fisher Scientific Inc.: Revenue, 2018-2020
Table 35: WuXi AppTec: Revenue, 2018-2020
Table 36: Abbreviations and Acronyms
Summary Table: Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, Through 2026
Table 1: R&D Investment, by Major Companies, 2019-2020
Table 2: Leading CROs in India
Table 3: Companies in the API Manufacturing Sector/Average Annual Revenues
Table 4: Companies Providing Formulation and Dosage Design Services for Drug Development (Examples)
Table 5: Distribution of Company Shares of the CDMO Sector by Revenue Range
Table 6: Companies Providing Analytical Testing Method Development and Validation Services for Drug Development (Examples)
Table 7: Companies Providing Drug Metabolism and Toxicology Services for Preclinical Drug Development (Examples)
Table 8: New Drug Approvals in the Global Biopharmaceuticals Market, 2006-2021
Table 9: Approved Drugs Repurposed for Infectious Diseases
Table 10: Global Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 11: Global Market for Discovery Services, by Region, Through 2026
Table 12: Global Market for Chemistry Services, by Region, Through 2026
Table 13: Global Market for Bioanalysis Services, by Region, Through 2026
Table 14: Global Market for Toxicology Services, by Region, Through 2026
Table 15: Global Market for Preclinical Research Outsourcing Services, by Region, Through 2026
Table 16: North American Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 17: European Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 18: Asia-Pacific Clinical Trial Regulatory Bodies
Table 19: Asia-Pacific Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 20: RoW Market for Preclinical Research Outsourcing Services, by Functional Service, Through 2026
Table 21: Pharma and CRO Partnership Alliances for Preclinical Research Services
Table 22: Recent M&As in CROs and Pharma Outsourcing Sector, 2016-2021
Table 23: Porter’s Five Forces Analysis
Table 24: Service Offerings, Major CROs
Table 25: Charles River Laboratories: Revenues, 2018-2020
Table 26: Eurofins Scientific: Revenue, 2018-2020
Table 27: Evotec: Revenues, 2018-2020
Table 28: Frontage Labs: Revenue, 2018-2020
Table 29: ICON plc: Revenue, 2018-2020
Table 30: IQVIA: Revenues, 2018-2020
Table 31: LabCorp: Revenue, 2018-2020
Table 32: Medpace: Revenues, 2018-2020
Table 33: SGS SA: Revenue, 2018-2020
Table 34: Thermo Fisher Scientific Inc.: Revenue, 2018-2020
Table 35: WuXi AppTec: Revenue, 2018-2020
Table 36: Abbreviations and Acronyms
LIST OF FIGURES
Summary Figure: Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, 2020–2026
Figure 1: Drug Approval Timeline
Figure 2: FDA cGMP Manufacturing Guidance Documents
Figure 3: FDA Site Inspections
Figure 4: European cGMP Guideline Documentation
Figure 5: European Site Inspection Outcomes
Figure 6: Global Market Size and Growth of Preclinical Research Outsourcing Services, 2019-2026
Figure 7: Pharma R&D Spending, 2016-2026
Figure 8: Global Prescription Drug Sales, 2016-2026
Figure 9: Global Market Shares of Preclinical Research Outsourcing Services, by Functional Service, 2020
Figure 10: Global Market for Discovery Services, 2019-2026
Figure 11: Global Market for Discovery Services, by Region, 2019-2026
Figure 12: Global Market for Chemistry Services, 2019-2026
Figure 13: Global Market for Bioanalysis Services, 2019-2026
Figure 14: Global Market for Bioanalysis Services, by Region, 2019-2026
Figure 15: Global Market for Toxicology Services, 2019-2026
Figure 16: Global Market for Toxicology Services, by Region, 2019-2026
Figure 17: Global Market for Preclinical Research Outsourcing Services, by Region, 2020–2026
Figure 18: Global Market Shares of Preclinical Research Outsourcing Services, by Region, 2020
Figure 19: North American Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 20: European Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 21: Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 22: Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 23: Global Market Shares of Leading Preclinical Research Outsourcing Service Providers, 2020
Figure 24: Expanding Value, Outsourcing Deals Involving CROs, 2007-2017
Figure 25: SWOT Analysis of the DTC Testing Market
Figure 26: Charles River Laboratories: Revenue Share, by Segment, 2020
Figure 27: Eurofins Scientific: Revenue Share, by Segment, 2020
Figure 28: Evotec: Revenue Share, by Segment, 2020
Figure 29: Frontage Labs: Revenue Share, by Segment, 2020
Figure 30: IQVIA: Revenue Share, by Segment, 2020
Figure 31: LabCorp: Revenue Share, by Segment, 2020
Figure 32: SGS SA: Revenue Share, by Segment, 2020
Figure 33: Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2020
Figure 34: WuXi AppTec: Revenue Share, by Segment, 2020
Summary Figure: Global Market for Preclinical Research Outsourcing Services, by Preclinical Services, 2020–2026
Figure 1: Drug Approval Timeline
Figure 2: FDA cGMP Manufacturing Guidance Documents
Figure 3: FDA Site Inspections
Figure 4: European cGMP Guideline Documentation
Figure 5: European Site Inspection Outcomes
Figure 6: Global Market Size and Growth of Preclinical Research Outsourcing Services, 2019-2026
Figure 7: Pharma R&D Spending, 2016-2026
Figure 8: Global Prescription Drug Sales, 2016-2026
Figure 9: Global Market Shares of Preclinical Research Outsourcing Services, by Functional Service, 2020
Figure 10: Global Market for Discovery Services, 2019-2026
Figure 11: Global Market for Discovery Services, by Region, 2019-2026
Figure 12: Global Market for Chemistry Services, 2019-2026
Figure 13: Global Market for Bioanalysis Services, 2019-2026
Figure 14: Global Market for Bioanalysis Services, by Region, 2019-2026
Figure 15: Global Market for Toxicology Services, 2019-2026
Figure 16: Global Market for Toxicology Services, by Region, 2019-2026
Figure 17: Global Market for Preclinical Research Outsourcing Services, by Region, 2020–2026
Figure 18: Global Market Shares of Preclinical Research Outsourcing Services, by Region, 2020
Figure 19: North American Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 20: European Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 21: Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 22: Asia-Pacific Market for Preclinical Research Outsourcing Services, 2020–2026
Figure 23: Global Market Shares of Leading Preclinical Research Outsourcing Service Providers, 2020
Figure 24: Expanding Value, Outsourcing Deals Involving CROs, 2007-2017
Figure 25: SWOT Analysis of the DTC Testing Market
Figure 26: Charles River Laboratories: Revenue Share, by Segment, 2020
Figure 27: Eurofins Scientific: Revenue Share, by Segment, 2020
Figure 28: Evotec: Revenue Share, by Segment, 2020
Figure 29: Frontage Labs: Revenue Share, by Segment, 2020
Figure 30: IQVIA: Revenue Share, by Segment, 2020
Figure 31: LabCorp: Revenue Share, by Segment, 2020
Figure 32: SGS SA: Revenue Share, by Segment, 2020
Figure 33: Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2020
Figure 34: WuXi AppTec: Revenue Share, by Segment, 2020
